Levothyroxine Sodium (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Levothyroxine Sodium drug offered from Fresenius Kabi USA, LLC. This l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | LEVOTHYROXINE SODIUM ANHYDROUS |
| SUBSTANCE NAME: | LEVOTHYROXINE SODIUM ANHYDROUS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-06-24 |
| END MARKETING DATE: | 0000-00-00 |
Levothyroxine Sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Levothyroxine Sodium from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(ug/5mL) |
| START MARKETING DATE: | 2011-06-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-647_1001cac8-bb9d-4abc-bc8f-c4c28dc3839e |
| PRODUCT NDC: | 63323-647 |
| APPLICATION NUMBER: | NDA202231 |
Other LEVOTHYROXINE SODIUM ANHYDROUS Pharmaceutical Manufacturers / Labelers:
